บริษัท วนชัย กรุ๊ป จำกัด(มหาชน) - Translation - 30 June 2020 Subject : Disclosure of connected transaction by a subsidiary Attention : President The Stock Exchange of Thailand Vanachai Group Public
Microsoft Word - NWR 033_E_Year17 (Translation) No.FN-NWR 033/2561 28 February 2018 Subject : Submission of Financial Statements for the Years ended 31 December 2017 To : President The Stock Exchange
the year ended December 31, 2019 To Director and Manager the Stock Exchange of Thailand According to the Board of Directors’ Meeting No.2/ 2 0 2 0 of DOD Biotech Public Company Limited ( “ the Company
ended June 30, 2018 Attention: President The Stock Exchange of Thailand Oishi Group Public Company Limited and subsidiaries clarify consolidated operating results and consolidated financial statements for
transaction is deemed to be a transaction on acquisition of assets in accordance with the Notification of the Board of Governors of the Stock Exchange of Thailand Re: Disclosure of Information and Other Acts of
MD&A Q.2'18EN 1 RP-AC 003/201 AUGUST 1, 201 Subject: Clarification of the operating results for the second quarter of 2018 To: Directors and Managers of the Stock Exchange of Thailand Richy Place
Jor. 62/2561 Re: Offer for Sale of Bonds Denominated in Foreign Currency in the Kingdom of Thailand ________________ By virtue of Section 16/6 of the Securities and Exchange Act B.E. 2535 (1992), as
วันที่ 10 พฤษภาคม พ -Translation- 1 Ref. LPN/SorKor/025/2561 14th February, 2018 Re: Report of Financial Statement for Year 2017 Dear: President The Stock Exchange of Thailand L.P.N. Development
March 20, 2018 Subject The amendment of Information Memorandum on Acquisition of Assets To President The Stock Exchange of Thailand According, Bangkok Dec-con Public Company Limited has reported
IP_AC/001/2563 February 24, 2020 Subject Management’ discussion and analysis for the fiscal year ended December 31, 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited